Antimalarial drug resistance of Plasmodium falciparum in India: Changes over time and space

The Lancet Infectious Diseases

Volumn 11, Issue 1, 2011, Pages 57-64

  Shah, Naman K ^a   Dhillon, Gajender PS ^b   Dash, Adtiya P ^c   Arora, Usha ^b   Meshnick, Steven R ^a   Valecha, Neena ^c  

^a IL   (United States)

^b GOVERNMENT OF INDIA   (India)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; PRIMAQUINE; PYRIMETHAMINE; SULFADOXINE;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG MONITORING; HEALTH CARE POLICY; INDIA; MALARIA; MALARIA CONTROL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; GEOGRAPHY; HUMANS; INDIA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650233941     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70214-0     Document Type: Review

References (37)

1. Sharma VP Current scenario of malaria in India. Parassitologia 1999, 41:349-353.
2. Akhtar R, Learmonth A, Keynes M The resurgence of malaria in India 1965-76. Geo J 1977, 1:69-80.
3. Sharma VP Re-emergence of malaria in India. Indian J Med Res 1996, 103:26-45.
4. Epidemiology and control of malaria in India 1996, National Malaria Control Programme, Delhi. R.S. Sharma, G.K. Sharma, G.P.S. Dhillon (Eds.).
5. Pattanayak S, Roy RG Malaria in India and the modified plan of operations for its control. J Commun Dis 1980, 12:1-14.
6. Valecha N, Joshi H, Mallick PK, et al. Low efficacy of chloroquine: time to switch over to artemisinin based combination therapy for falciparum malaria in India. Acta Trop 2009, 111:21-28.
7. Sehgal PN, Sharma MTD, Sharma SL, et al. Resistance to chloroquine in falciparum malaria in Assam state, India. J Commun Dis 1973, 5:175-180.
8. Das S, Barkakaty BN, Roy JR, et al. Pyrimethamine in combination with sulfadoxine or sulfalene in P. falciparum infected cases in India. Indian J Malariol 1981, 18:109-116.
9. National drug policy on malaria (accessed Aug 5, 2010). http://nvbdcp.gov.in/Doc/drug-policy-2010.pdf.
10. Dua VK, Dev V, Phookan S, Gupta NC, Sharma VP, Subarao SK Multi-drug resistant Plasmodium falciparum malaria in Assam, India: timing of recurrence and anti-malarial drug concentrations in whole blood. Am J Trop Med Hyg 2003, 69:555-557.
11. Valecha N, Srivastava P, Mohanty S.S, et al. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India. Malar J 2009, 8:107.
12. Arora U, Sonal GS, Dhillon GP, Thakor HG Emergence of drug resistance in India. J Indian Med Assoc 2008, 106:678-681. 683.
13. Valecha N Recent developments in malaria chemotherapy. Proc Nat Acad Sci India 2009, 79:23-35.
14. Valecha N, Joshi H, Eapen A, et al. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg 2006, 100:831-837.
15. Methods for surveillance of antimalarial drug efficacy 2009, World Health Organization, Geneva, (accessed Aug 5, 2010). http://www.who.int/malaria/resistance.
16. Prasad RN, Prasad H, Virk KJ, Sharma VP Application of a simplified in-vivo test system for determining chloroquine resistance in Plasmodium falciparum. Bull World Health Organ 1990, 68:755-758.
17. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Group 1973, World Health Organization, Geneva.
18. Assessment of therapeutic efficacy for uncomplicated falciparum malaria in areas with intense transmission 1996, World Health Organization, Geneva.
19. Gogtay NJ, Kadam VS, Desai S, Kamtekar KD, Dalvi SS, Kshirsagar NA A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India. J Assoc Physicians India 2003, 51:877-879.
20. Sharma VP Battling the malaria iceberg with chloroquine in India. Malar J 2007, 6:105.
21. Verdrager J, Riche A, Chheang CM Traitement du paludisme a' P. falciparum par le sulfamideratard. Presse Med 1967, 75:2839-2840.
22. Clyde DF, Hlaing N, Tin F Resistance to chloroquine of Plasmodium falciparum from Burma. Trans R Soc Trop Med Hyg 1972, 66:369-370.
23. Rosenberg R, Maheswary NP Chloroquine resistant Plasmodium falciparum in Bangladesh. Trans R Soc Trop Med Hyg 1976, 70:533.
24. Malaria drug resistance Southeast Asia Regional Office, World Health OrganizationWorld Health Organization, (accessed July 8, 2009). http://www.searo.who.int/en/Section10/Section21/Section340_4039.htm.
25. Sharma VP Status of drug resistance in malaria in India. Multi-drug resistance in emerging and re-emerging diseases 2000, 191-202. Narosa Publications, Delhi. R.C. Mahajan, A. Therwath (Eds.).
26. Laufer MK, Thesing PC, Eddington ND, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 2006, 355:1959-1966.
27. Brockman A, Price RN, van Vugt M, et al. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg 2000, 94:537-544.
28. Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 2000, 356:297-302.
29. Misra SP In vivo resistance to chloroquine and sulfa pyrimethamine combination in Plasmodium falciparum in India. Proc Natl Acad Sci India 1996, 66:123-128.
30. Guidelines for the treatment of malaria 2006, World Health Organization, World Health Organization, Geneva.
31. Guidelines for the diagnosis and treatment of malaria in India 2009 National Vector Borne Disease Control Programme, (accessed July 8, 2009). http://www.nvbdcp.gov.in/Doc/Guidelines-Diagnosis-Treatment-Mal-2009.pdf.
32. Dash AP, Valecha N, Anvikar AR, Kumar A Malaria in India: challenges and opportunities. J Biosci 2008, 33:583-592.
33. Guidelines for the diagnosis and treatment of malaria in India 2009 National Institute of Malaria Research, (accessed July 8, 2009). http://www.mrcindia.org/Guidelines_for_Diagnosis_and%20Treatment.PDF.
34. Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring 1996-2004 2005, World Health Organization, World Health Organization, Geneva.
35. Talisuna AO, Bloland P, D'Alessandro U History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev 2004, 17:234-254.
36. Mohapatra PK, Namchoom NS, Prakash A, et al. Therapeutic efficacy of anti-malarials in Plasmodium falciparum malaria in Indo-Myanmar border area of Arunachal Pradesh. Indian J Med Res 2003, 118:71-76.
37. Dondrop AM, Noston F, Poravuth Y, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.